34 Engineering Ethics: An Industrial Perspective
Herper, M., Face of the Year: David Graham. Forbes, December 13, 2004. http://www.forbes.com/
Jacobs, P., Medical firm’s dangerous secret device’s troubles were well known at Menlo Park
company. San Jose Mercury News, 1A,August 3, 2003.
Kumagai, J.,The whistle-blower’s dilemma, IEEE Spectrum,April 2004, 41, 53–55.
Lewis, M., The irresponsible investor. NY Times Mag, 68, June 6, 2004.
Meier, B., Acting alone, Mississippi settles suit with 4 tobacco companies. NY Times, A1, July
Nguyen, T., Refiled under “U”: Taking a page from history? Try not to sweat. Wash Post, D01,
July 25, 2004.
NOW, David Graham Transcript, NOW on PBS Television Program, January 7, 2005.
Occupational Safety and Hazard Administration, Whistleblower Protection OSHA Fact Sheet.
Washington, DC: OSHA, Department of Labor, 2003.
Project on Government Oversight (POGO), Media Briefer: Whistleblower Protection Act. July
7, 2001. http://www.pogo.org/p/government/ga-010707-whistleblower.html.
Project on Government Oversight, Whistleblower Protections Included On Homeland Security
Bill. July 12, 2002. http://www.pogo.org/p/government/ ga-020724-whistleblower.html.
Schinzinger, R. and Martin, M. W., Introduction to Engineering Ethics. Boston: McGraw-Hill,
2000, 167–168, 178.
Walsh, D.,Whistle-blowers get $8.1 million, Sacramento Bee, B1, January 8, 2004.
Watchman, G. R., Sarbanes-Oxley Whistleblowers: A New Corporate Early Warning System.
Washington, DC: Government Accountability Program, 2002. http://www.whistleblower.org/
QUESTIONS FOR DISCUSSION
1. In December 2002, Time magazine named Sherron Watkins and two
other women, Cynthia Cooper and Coleen Rowley, as their “Persons
of the Year.” What did Ms. Cooper uncover? How was she treated by
fellow employees? How did her revelation affect WorldCom?
2. View The Insider, a 1999 feature film produced by Brugge that details
how investigative journalism was involved in exposing corporate tobacco
dishonesty. Insider conscience Dr. Jeffrey Wigand was portrayed by
Russell Crowe. What were Wigand’s motivations for disclosing confi-
dential Brown and Williamson information? Did these motivations
decrease the credibility of his information?
3. In the summer of 2004, in the midst of emerging evidence that the
drug Vioxx increased the risk of heart attack or stroke, Dr. David Graham
was preparing to give his own talk on Vioxx at an international pharma-
coepidemiology conference in France. Graham, an associate director of
science at the FDA Office of Drug Safety, had conducted a study that
demonstrated that both low and high doses of Vioxx increased the risk
of heart attack compared with another drug in the same class, Celebrex.
Ch02-P088531.qxd 2/22/06 11:44 AM Page 34